AIHTA - Publications - Search - Items where Subject is "QU 300-375 Cells"
Number of items at this level: 12.

Eder, C. and Wild, C. (2019): Advanced Therapy Medicinal Products (ATMPs): Technology forecast. Journal of Market Access & Health Policy 7 (1).

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Geiger-Gritsch, S. (2020): CAR-T Cell Therapies, ATMP and Gene Therapies in Development, Horizon Scanning: CAR-T Cell Therapy. AIHTA Policy Brief 006a.

Langer, T. (2006): [Stem cell transplantation for acute leukemia]. HTA-Newsletter 52: pp. 2-3.

Pramesberger, C. and Adlbrecht, C. and Guba, B. and Felder-Puig, R. (2008): [New minimally invasive methods in the treatment of stress urinary incontinence. Systematic review]. Decision Support Document 06.

Wild, C. and Wohlhöfner, K. and Sehic, O. and Grössmann, N. (2020): CAR-T Cell Therapies, ATMP and Gene Therapies in Development, Horizon Scanning: ATMPs and Gene Therapies. AIHTA Policy Brief 006b.

Wild, C. (2003): [High-dose chemotherapy]. HTA-Newsletter 22: p. 4.

Wild, C. (2001): [Stem cell research, quo vadis? Editorial]. HTA-Newsletter 03: pp. 1-2.

Wild, C. (2001): [Stem cells: Quo vadis?]. ITA-Newsletter September 2001: pp. 8-9.

Wild, C. (2001): [Stem cell research, quo vadis?]. ORF ON Science.

Wild, C. and Grössmann, N. (2019): FoundationOne®CDx: genetic profiling of solid tumours. Rapid Assessment 014.

Wolf, S. and Stanak, M. (2018): Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas. Decision Support Document 111.

This list was generated on Mon Oct 26 01:00:16 2020 CET.